BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35952681)

  • 21. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
    Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
    J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    Planta Med; 2001 Aug; 67(6):510-4. PubMed ID: 11509969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.
    Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S
    Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol.
    Ciriza I; Carrero P; Azcoitia I; Lundeen SG; Garcia-Segura LM
    J Neurobiol; 2004 Nov; 61(2):209-21. PubMed ID: 15389604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulators of androgen and estrogen receptor activity.
    Clarke BL; Khosla S
    Crit Rev Eukaryot Gene Expr; 2010; 20(4):275-94. PubMed ID: 21395502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation.
    Bryant HU
    Rev Endocr Metab Disord; 2001 Jan; 2(1):129-38. PubMed ID: 11704975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selective estrogen receptor modulators (SERMs)].
    Chaki O
    Nihon Rinsho; 2015 Oct; 73(10):1673-81. PubMed ID: 26529929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators.
    Ji Q; Gao J; Wang J; Yang C; Hui X; Yan X; Wu X; Xie Y; Wang MW
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2891-3. PubMed ID: 15911274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
    Reiter R; Oh AS; Wellstein A; Riegel AT
    Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct mechanisms of action of selective estrogen receptor modulators in breast and osteoblastic cells.
    Nuttall ME; Stroup GB; Fisher PW; Nadeau DP; Gowen M; Suva LJ
    Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1550-7. PubMed ID: 11029302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
    Musa MA; Khan MO; Cooperwood JS
    Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New selective estrogen receptor modulators (SERMs) in development.
    Silverman SL
    Curr Osteoporos Rep; 2010 Sep; 8(3):151-3. PubMed ID: 20603714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.
    Hemachandra LP; Patel H; Chandrasena RE; Choi J; Piyankarage SC; Wang S; Wang Y; Thayer EN; Scism RA; Michalsen BT; Xiong R; Siklos MI; Bolton JL; Thatcher GR
    Cancer Prev Res (Phila); 2014 May; 7(5):505-15. PubMed ID: 24598415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors.
    Bramlett KS; Burris TP
    Mol Genet Metab; 2002 Jul; 76(3):225-33. PubMed ID: 12126937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).
    Lewis-Wambi JS; Jordan VC
    Breast Dis; 2005-2006; 24():93-105. PubMed ID: 16917142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.